Publication Ethics

Authors may decide on submitting their manuscript as a word file to be applied in the reviewing process. during the revision process, authors will be asked to put their paper in to a 'correct format' for accepting and prepare the items essential for publishing the manuscript. If authors submit their manuscripts to the journal for publishing in a particular issue, they should communicate with the Editor-in-Chief or Guest Editor to know about the submission instructions. Authors should avoid submitting their manuscript via the online Medbiotech Journal unless authors are requested to do so. 

Authorship Guidelines

Authorship credit should be according to: (i) considerable aids to conception and design, attainment of data, or analysis and explanation of data, (ii) Drafting the manuscripts or revising it critically for significant intellectual content; and (iii) Final acceptance of the version to be submitted for publishing. These conditions should be fulfilled by all authors. Gaining the subsidy, collecting the data or general supervision of the research group alone does not establish authorship. All contributors not satisfying the conditions for authorship should be named in an acknowledgments section. The authors are responsible for reaching an agreement on the order of their names before the submission of the manuscript. The authors should agree to appoint one author as the corresponding author for submitting. The corresponding author should take the responsibility for organizing the entire manuscript according to the Medbiotech Journal requirements and for communicating with the co-authors during the peer review process and the proofing stages.

To find out more, please visit the Preparation section below.

 

BEFORE YOU BEGIN

Ethics in Publishing

The Medbiotech Journal bases its ethical policy on the Committee on Publication Ethics (COPE) guidelines which is in accordance with International Committee of Medbiotech Journal Editorial Board codes of conduct. Authors, reviewers, readers and editors should pursue these moral policies when work with Medbiotech Journal. The ethical policy of Medbiotech Journal is responsible for specifying which of the submitted manuscripts should be published in the specific issue. The final decision is made according to reviewers and editorial board members' suggestions. The journal's ethical policy makes Editor-in-Chief to consult with other editors or reviewers to make their final decision. The reviewers are responsible for assessing the manuscripts according to their contents in a confidential way. The reviewers recommend the authors for improving the quality of their paper by applying their reviewers' comments. Authors should guarantee that the manuscript submitted to the Medbiotech Journal is original and has not been published in other journals in any language. Authors should follow the copyright rules and agreements. Any kind of plagiarism founds unethical publishing conduct and is unacceptable. For information regarding publishing and ethical guidelines please refer to http://publicationethics.org.

 

Peer-Review Process

authors have the responsibility for taking part in in peer review process to assess manuscripts in order to assist the peer review system. If necessary, authors should be forced to provide the editors and the publisher with retractions and/or modifications of errors. All submitted manuscripts to Medbiotech Journal will undergo the peer review process at least one round.  Medbiotech Journal pursue a double-blinded review policy: authors are unsighted to reviewers, but reviewers are not unsighted to authors. The peer review process is carried out through the online manuscript submission and peer-review system. As soon as submitting the manuscript to the online system, the system informs the editorial office straightaway. After evaluating the initial quality of the manuscript by the editorial office, the manuscript will be sent to two or more reviewers. The editorial boards are responsible to make the final decision after sending the comments by reviewers. Since there may be disagreements between reviewers, the final decision sent to the author may not indicate the recommendations given by each of reviewers. In order to assist the peer review system, authors have the responsibility for taking part in peer review process to assess manuscripts. 

The decision made after each stage of peer-review may be according to one of the following"

  1. Accept without any additional alternations.
  2. Accept with minor revision. The manuscript after revision may or may not be sent to the reviewers for receiving further comments.
  3. Reject with encouraging the author to resubmit the manuscript. In this case major revisions are essential for resubmitting. The revised manuscript which is resubmitted to the journal will undergo the peer-review process for the second time. In general, it will be sent to the original reviewers.
  4. Reject without encouraging the authors to resubmit. The manuscript is rejected for publishing in Medbiotech Journal.

Post-Publication Evaluation

As well as quick the peer-review process, the Medbiotech Journal is assessed through Post-Publication Evaluation by the scientific community.

The main purpose of Post-Publication Evaluation is making sure that the quality of the published manuscript satisfies the required standards and the given conclusions are justified. The post-publication evaluation process consists of offering online comments and citations on published papers. Authors may reply to the comments offered by the scientific community and may revise their manuscript. The Post-Publication Evaluation is explained in such a manner; it let authors to disseminate rapidly regarding biology, biotechnology, chemical sciences and medical sciences, 

Preparation of Manuscripts

Submitted manuscripts must be written in English and authors are responsible for using accurate grammar and appropriate terminology. Manuscripts should be typed in Camberia of 10 pt. font and in MS Word format in one column with 2.5 cm margin at each side. The submission of the manuscript must be carried out in order to get one submission ID number. Submission the manuscript more than once can miss the chance of the manuscript consideration. All Manuscripts should be submitted along with a cover letter including title and author(s) name.

 

English Language Writing

All manuscript in the Medbiotech Journal are in English. Authors whose first language is not English should ensure that their manuscripts should be translated to English before submitting. Authors should write their manuscript in only one of American or British spelling. Medbiotech Journal does not provide the authors with language and copy-editing services, therefore authors should take actions regarding removing the grammatical or spelling errors before the submission. It should be noted that authors are responsible for the cost of such services.    

 

New Submissions

Authors should submit their manuscript to Medbiotech Journal through the online submission system and authors are given guidance step by step when upload their manuscripts. As part of the manuscript, authors may choose to submit the manuscript as a single file to be used in the refereeing process.  this manuscript can be as a word document, that can be used by reviewers to assess the manuscripts. All figures, tables and complementary data should be embedded in the main manuscript file

 

References

Authors should use Vancouver style for the references. All authors must use EndNote for inserting references to their manuscripts. As far as possible, authors' name, year of publication, journal abbreviated title/book title, chapter title/article title, volume number/book chapter and the pagination must be present.

 

Formatting requirements

There are no stringent formatting necessities but all submitted manuscripts must include the crucial elements required to convey your manuscript, such as Abstract, Keywords, Introduction, Materials and Methods, Results and Discussion, Conclusion, Acknowledgement and Conflict of Interest. Authors should make sure that all figures, tables and complementary data should be included in the main manuscript file.

 

Revised Submissions

Without regard to the first submission's file format, authors must submit their manuscript according to the Medbiotech Journal format at revision stage.  The layout of the manuscript should be kept simple as far as possible. Authors are strongly recommended to employ the 'spell-check' and 'grammar-check' for the submitted manuscript to avoid potential errors.

 

Manuscript Submission and Declaration

All contributing author(s) must confirms that the submitted manuscript signifies genuine and reliable work and guarantee that their manuscript has not been published or being regarded for publishing in other journals in English or in other language. All contributing authors should reach an agreement on choosing the corresponding author to be in touch with the editorial office, to review the edited manuscript and proof. All contributing authors are responsible for filling in and sending an Authorship Statement Form after submitting their manuscript to the Medbiotech Journal. Furthermore, the corresponding author should recognize all authors’ participation in the manuscript. People contributing to the work described in the manuscript such as collecting and analyzing data, writing or revising the manuscript but do not meet the authorship criteria should be listed in the Acknowledgments Section. It will beneficial for specifying the nature of the reported work. The contributing author(s) guarantees that the presented data should be illustrated in the manuscript and the manuscript should be included adequate references to reproduce the work by others. If authors assert compensation, the publisher will not take the responsibility lawfully. 

 

Manuscript Submission and Verification

It is supposed that manuscripts have not been published elsewhere either in in print or electronic version and are not under review by another journal. The copy version of repeated materials (such as the manuscripts containing same or similar data) that have been disseminated beforehand or are under review by another journal must be sent at the submission stage.   

 

Manuscript Structure

The manuscript's structure must be organized as: Title; Abstract; Keywords; Introduction; Materials and Methods; Results and Discussion; Conclusion; Acknowledgements and References that are submitted in a file with restricted size.

 

 

Title Page

-The title should include the name(s) of the author(s)

-  the title should be brief but informative

- The title should include the authors' affiliation(s) and address(es)

- The title should include the e-mail address, telephone and fax numbers of the corresponding author

 

Manuscript Title

Title of manuscript should not contain more than 17 words and should not contain the name of locations, countries or cities of the research as well as abbreviations. Authors should avoid using complex and technical languages and ambiguous expressions. The title should be in favor of biotechnology while not being vague or worthless.

 

Abstract

An abstract must accompany each manuscript. It should be a brief summary of the significant items of the main paper. An abstract should not normally exceed 250 words. It should not contain literature citations or allusions to the tables or illustrations. All non-standard symbols and abbreviations should be defined. 

Keywords

List of all keywords proposed by the authors, separated by commas. It is recommended that authors provide 5 to 7 keywords used for indexing purposes. Authors should avoid repeating the title's words or using undefined abbreviations. Keywords should be written in alphabetical sequence and separated by semicolon.

Highlights

Highlights are compulsory for Medbiotech Journal. Highlight should be A brief, short phrase expressing the fundamental findings of your research. Authors should use 'Highlights' in the file name and include 3 to 4 items. The average length of a highlight item may be approximately 1 to 1.5 lines.

 

Graphical Abstract

Graphical Abstract is a brief, graphic and visual summary of the major findings of the article where it can be learnt more from the instruction at the link below or viewing from the Medbiotech Journal published articles graphical published articles graphical abstract: https://www.elsevier.com/authors/journal-authors/graphical-abstract

Graphical abstract must be submitted along with the manuscript's submission. Graphical Abstract should visualize the key findings of the manuscript briefly. It should be related to the manuscript's topic and contribute to capture readers' attention.

 

Introduction

The Introduction should express the aim of research and clarify the knowledge gap which will be reviewed in the Literature review section. Authors should mention date and location of the research conducted at the end of this section.

 

Materials and Methods

The Materials and Methods section should represent sufficient data to allow readers to repeat the experiments. Sampling procedures, experimental design, and essential sample characteristics and descriptive statistics, hypothesis, references to literature describing the tests used in the manuscript should be mentioned clearly. Chemical compounds should be named according to the systematic rules of IUPAC or Chemical Abstracts. Common trivial names that are accepted by IUPAC can also be used. Units and dimensions should be expressed according to the metric system and SI units.  

 

Results and Discussion

The Results section should express the findings of study. Authors should present the obtained data briefly. Authors should avoid using very large tables as far as possible. The Discussion should be an interpretation of the results and their significance with reference to work by other authors. Please note that the policy of the Journal with respect to units and symbols is that of SI symbols.

 

Tables

Authors should not submit their tables and graphs like photographs. Tables and graphs should be embedded in the manuscript. Do not use internal horizontal and vertical rules. Tables should be included within the manuscript and should have a clear and logical rational structure along with successive numerical order. All tables should be numbered (1, 2, 3, etc.). sufficient information should be provided using subtitles, as a result tables are comprehensible without referring to the manuscript. Authors must write a caption for each table describing the table's components. Pervious published materials should be identified by giving a reference at the end of the caption. Table caption should be placed above and it should be numbered. Footnotes should be specified by superscript lower-case letters and embedded below the table body.

 

Figures

The quality of figures/ illustrations should be high, within 200-300 dpi. Figures should be submitted separately in the Excel format. Authors should guarantee that figures are vivid, labeled and of a size that can be published clearly in the journal. Figures should be embedded in the text. Authors should pay attention to the following remarks:

- Each figure should have a brief caption explaining precisely what the figure illustrate. Captions should be written in the text file, not in the figure file.

- Figure captions should be located under the figures in restricted numbers.

- Authors should not use any punctuations at the end of the caption.

- Authors should determine all elements existed in the figure in the caption and use circles, boxes such as coordinate points in graphs.   

- Pervious published materials should be identified by citing the references at the end of the caption.

 

Conclusion

In the conclusion section, authors should highlight the main findings and mention how their discoveries can cover the knowledge gap without giving references.

 

Acknowledgements

Appreciation of people, grants, subsidies, etc. should be mentioned in the Acknowledgements section before the reference list. The names of supportive organizations should be written in full. If authors receive any financial support, it must be stated in this section.

 

Conflict of Interest

A Conflict of Interest statement must be included for all manuscripts as below:

"The authors affirm that there are no conflicts of interest concerning the publication of this manuscript".

 

Abbreviations

A list of abbreviations should be included within the manuscript in which all symbols and undefined abbreviations should be defined clearly. Authors should avoid adding abbreviation in the abstract. It should be noted that the list of abbreviations must be written in alphabetical order. If your manuscript does not include any abbreviation, just mention “Not applicable” in this section.

 

References

A complete reference should give the reader enough information to find the relevant article. Authors should cite the references through the manuscript, all references in the reference list should be organized according to Vancouver style. References should be numbered chronologically. The number of references adopted from each journal should not go beyond 5. It is suggested that the number of references should be more than 30 for original papers and more than 100 for review papers. It is also suggested that the authors should refer to recent research which have carried out in the last 10 years. Authors should use Vancouver style for volume, issue and pages. Authors should ensure that all references cited in the manuscript should also be exist in the reference list.       

 

Text

All citations in the manuscript should be according to the following:

1. Single author: the author's name (without initials, unless there is vagueness) and the year of publication; 

2. Two authors: both authors' names and the year of publication; 

3. Three or more authors: first author's name followed by "et al.," and the year of publication.

Citations may be mentioned straight. In case of citing the groups of references, the references should be listed first alphabetically and then chronologically. For instance: "as demonstrated (Allan, 1996a, 1996b, 1999; Allan and Jones, 1995). Kramer et al., (2000) have recently shown ..."

 

List 

References should be organized chronologically. As regards the references from the same Author(s) in the same year, authors should specify these references using letters "a", "b", "c", etc., located after the year of publication. 

 

Journal article

Nouri J.; Lorestani B.; Yousefi N.; Khorasani N.; Hassani A.H.; Seif F.; Cheraghi, M. 2011. Phytoremediation potential of native plants grown in the vicinity of Ahangaran lead-zinc mine.  Environ. Earth Sci., 62(3): 639-644.

 

Instruction for citing references in EndNote

It is strongly recommended that authors use Endnote according to Vancouver style.

 

Book 

Davis M.L. 2005. Introduction to Environmental Engineering, 3rd. Ed. McGraw Hill Inc.

 

Book chapter 

Mettam G.R.; Adams L.B. 1999. How to prepare an electronic version of your article, in: Jones B.S., Smith R.Z. (Eds.), Introduction to the electronic age. E-Publishing Inc., New York.

 

Conference paper 

Brown J. 2005. Evaluating surveys of transparent governance. In UNDESA, 6th. Global forum on reinventing government: towards participatory and transparent governance. Seoul, Republic of Korea 24-27 May. United Nations: New York.

 

Dissertation 

Trent J.W. 1975. Experimental acute renal failure. Ph.D. Dissertation, University of California. USA.

Medbiotech Journal sent a revision and proof to the authors and ask them to complete and sign it before accepting the manuscript for publication. The corresponding author is responsible for the precision of the bibliography.   

 

Authorship

All participating authors should be eligible for authorship. The co-authors should decide on the order of the authorship. Adequate contribution in the work is of great significance. Please refer to:

https://drive.google.com/file/d/1o38IVKAj3GFikadNqkwfBwpxjrROkN44/view?usp=sharing

Authorship credit should be according to considerable involvement in conception and design, execution, or analysis and interpretation of data. All authors should take part in preparing a draft of the article or revising it, they also must have read and confirmed the final version of the manuscript and confirm its submission to the Medbiotech Journal.

 

Changes to Authorship

After the acceptance of the manuscript for publishing, the corresponding author is responsible for sending a request regarding adding or removing an author's name or organizing the order of authors' name as following:

The corresponding author must send an email to the Medbiotech Journal editor-in-chief and explain clearly why the name should be added or removed, why the authors' names should be re-ordered and all contributing authors should sign the authorship form to make required changes. (https://drive.google.com/file/d/1o38IVKAj3GFikadNqkwfBwpxjrROkN44/view?usp=sharing)

only requests which are sent by the corresponding author are acceptable, otherwise the editor-in-chief sent the requests back. It should be noted that any authorship changes are not allowable after publishing the manuscript. Note that: (1) Journal Managers will notify the Journal Editors of these requests and (2) publishing the accepted manuscript in an online issue is postponed until all authors reach an agreement authorship has been agreed.  

 

Copyright

All Journals should clarify the type of copyright. As soon as accepting manuscript, authors are requested to fill in a 'Journal Publishing Agreement'.

(https://drive.google.com/file/d/1XwpOfD42SCI5iyzIOX0hAcCR3QTK_H5i/view?usp=sharing).   

Afterwards, Medbiotech Journal will send an email to the corresponding author approving receiving the manuscript along with a 'Journal Publishing Agreement' form.

 

Permission required

Permission should be got from the publisher to publish any substantial part of a copyrighted work which relies on both the importance of the material and the quantity of material used. This contains any text, pictures, charts, tables, photographs, or other material from the manuscript published beforehand.  If parts of other copyrighted works are contained, the author(s) must gain written permission from the copyright publisher.

 

Permission not required

Copyright guards only original material. Therefore, it only guards specific particular form of expression of a work and not concepts or facts included in it. Public works which are not guarded by copyright and may be published without permission. However, permission would be compulsory to re-use the final version of the published work in certain cases, since the publisher is its owner.

 

Open Access Publication

Medbiotech Journal disseminate the manuscripts covering an extensive diversity of areas. All papers disseminate in Medbiotech Journal are open access and dispersed under open access license agreement. According to this license, authors remain the possession of the research work but readers are allowed to download, reuse, reprint, modify, distribute, and/or copy the content since they refer to the original article in their manuscript. There are two different kinds of licenses viz., author agreement and user agreement, which are need to be described throughout the publication process.

 

Author Agreement

the publishers require publishing rights to publish the authors’ research work. the publisher applies a monopolized licensing agreement in which authors maintain copyright in their manuscript for open access articles.

(https://drive.google.com/file/d/1XwpOfD42SCI5iyzIOX0hAcCR3QTK_H5i/view?usp=sharing)

 

User license Agreement

Users or readers can have access to archived research work via Medbiotech Journal archives. All manuscripts are parts of open access archive which are available freely on the Medbiotech Journal website. Users or readers of authors’ manuscript should be informed about how they can use the manuscript. Reading and downloading all published research work are free as soon as publications. Readers can get permission to reuse the research work under "Creative Common Attribution" license. 

 

Creative Commons Attribution

Allow others to give out and copy the manuscript, to produce extracts, abstracts, and other revised versions, adaptations work of or from manuscript, to include in a cooperative work, to text or data mine the article, even for commercial purposes, on the assumption that they credit the author(s), do not express the author as supporting their adaptation of the article, and do not revise the article to hurt the author's pride or fame. Further information can be seen at: Creative Commons Attribution 4.0 International (CC BY 4.0)

 Conflict of Interest

Authors are asked to clarify whether imminent conflicts are present or not. If an organization has any financial benefit in the outcome of research work, the authors should prepare a statement that access to the data of the research work and shoulder the responsibility for integration of the data and precision of the data analysis. All research work must be confirmed by the relevant Ethics Committee/ Institution review board of the relevant organizations. Authors who want to use figures, tables, or text passages that have already been disseminated in other journals have to get permission from the publisher for both print and online versions and to contain indication that such permission has been awarded at the time of submission of manuscripts. It is supposed that manuscripts received without such evidence is originated by the authors.

As soon as accepting the manuscript, the corresponding author is responsible for signing the copyright transfer agreement for publishing towards the journal ethics and privacy policy. Medbiotech journal will inform the authors about appropriateness of their research work for publishing in the journal. As soon as acceptance of the manuscript, it will be revised and typeset, afterwards the editor-in-chief will send a proof to the corresponding author to make final revisions. Except for revising the typographical errors, other changes cannot be made at this stage. It should be noted that there is no page charge for publishing in Medbiotech Journal. The submitted materials may be taken into account for coverage but cannot be returned and the Journal's editors have the right to accept or reject any manuscript in any stage, if required.

 Further information on about Conflict of Interest Disclosure form can be found at: 

https://drive.google.com/file/d/1AJkW59t2mW0Hq7wBPiaQKFRsPYqBU-VL/view?usp=sharing

 

Role of Funding Source

Authors are responsible to clarify the individuals or organizations supporting their research work financially and should explain the role that the sponsor plays in conducting the research work such as designing and conducting of the study, collecting the data, management of data, analyzing and interpreting data, preparation, review and approval of the manuscript.

  1. The sentence should start with: ‘This research work was subsidized by …’.
  2. The full name of funder or sponsor should be mentioned; abbreviations are not acceptable.  
  3. Funding numbers should be comprehensive and precise and provided in brackets such as following: ‘[funding number ABX CDXXXXXX]’
  4. Multiple funding numbers should be separated by a comma as follows: ‘[grant numbers ABX CDXXXXXX, EFX GHXXXXXX]’
  5. The name of funders or sponsors should be separated using a semi-colon (plus ‘and’ before the last funding sponsors) 

Standard Reporting Guidelines

Authors are responsible for reporting their research work correctly. Original research work should be included enough details to enable other researchers to repeat the work. Review articles should be contained significant work by researchers in a specified area and should be accurately written.

Life Science Reporting Guidelines

Authors are responsible for reporting participation of dangers, human or animal subjects, patient images, case details, and other resources and information. Their experiments should be carried out according to the rules and related institutional instructions. If necessary, authors should provide the morals committee with approval documents, agreement on publishing personal information such as pictures of individuals, and other essential documents employed in the approval process. Furthermore, it should be mentioned within the manuscript that appropriate satisfaction has been gained for experiments with human subjects.

 

Errors in Published Papers

It is the authors' responsibility to inform the Medbiotech Journal editors when they find out mistakes or inaccuracy in the disseminated manuscript. Eventually, the corresponding author should make sure that all co-authors have read and confirmed the last version of the manuscript and reached an agreement on submitting it for publishing.

 

Plagiarism Prevention and Violation of Publication Ethics

All manuscript that are published or even under review in the Medbiotech Journal are screened by Plagiarism Prevention Software called iThenticate. Plagiarism is a breach of publication morals. Other violations such as repetitive publication, data fabrication and distortion, and inappropriate credit of author participation. Therefore, the Plagiarism or Fraudulent or intentionally incorrect statements form immoral conduct which are unacceptable and. As a result, submitting the same manuscript to more than one journal simultaneously constitutes immoral publishing conduct and is unacceptable. It should be noted that Medbiotech Journal may overlook a repeated manuscript up to 15%.

The CrossCheck provide the editors with helps to confirm originality of manuscript. CrossCheck is carried out using the Ithenticate software from iParadigms. In order to find a list of journal provided with CrossCheck, authors should refer to www.ithenticate.com/search

All manuscripts submitted to Medbiotech Journal are screened by CrossCheck in the editorial system. Editorial boards may provide a similarity report throughout the under review process or after publication. This report provides information about the percentage of similarity between the manuscript and other published papers. Checking the figures and equations is not possible. It should be noted that high percentage of similarity does not certainly mean plagiarism. For example, a similarity of 30% can signify that 30% of the manuscript is in common with one paper or there is 1% in common with 30 different papers.      

Prior to using the CrossCheck for the first time, it is strongly recommended that all reviewers and editorial boards read the manual supplied by ithenticate: Detailed User Manual 

 

Covering Letter

The covering letter include the manuscript's title, the details of the corresponding and contributing authors, the field of study, the type of manuscript as well as 3 reviewers for reviewing the manuscript. Moreover, the corresponding author should claim that the manuscript is in consistent with the Medbiotech Journal guide for authors. The covering letter samples can be seen at: 

https://drive.google.com/file/d/1N-s6Pe2jBoHUObwWyRvj97iWSsPsMdeK/view?usp=sharing

   

Submission Final Checklist

The corresponding author must revise the manuscript according to the following instructions before the acceptance and also the marked checklist should be submitted together with the covering letter:

General Considerations

  1. Authors must read the Medbiotech Journal’s Guide for Authors at: http://www.Medbiotech.net/journal/authors. Authors must ensure that their manuscript including text, tables, figures, and photographs must fulfill the Medbiotech Journal requirements.
  2. The manuscript includes the main sections described in Journal’s Guide for Authors; for instance, title, abstract, introduction, materials and methods, results and discussion, conclusion, appendices, acknowledgments, conflict of interest and references.
  3. The spelling of the manuscript must be checked.
  4. Prior to submission to Medbiotech Journal, authors are responsible for reading the publication ethics, Plagiarism prevention, breaches of publication ethics and Handling cases of misconduct.
  5. All contributing authors must approve the Manuscript.
  6. It is recommended that both the Corresponding author and co-authors register at Medbiotech Journal website to retain their names in the manuscript biosketches.
  7. Before the acceptance of the manuscripts, the corresponding author must sign the copy right release and conflict of interest revelation form. 

Title Page

- The title should include the name(s) of the author(s)

-  the title should be brief but informative

- The title should include the authors' affiliation(s) and address(es)

- The title should include the e-mail address, telephone and fax numbers of the corresponding author

- 5 to 7 keywords should be provided but not be stated in the title.

 

Text Format

 

  1. The manuscript should be in one column format.
  2. Abstract should be short and not normally exceed 250 words. It should be a brief summary of the significant results of the paper.
  3. Abstract should not contain references and abbreviations. All non-standard symbols and abbreviations should be defined. 
  4. The page number starts from the title page and it should be continuous from start to finish.
  5. tables and figures should not be contained the same data.
  6. Abbreviations that are used for the first time should be defined completely, then it can be used in the abbreviated form.
  7. The Introduction should express the aim of research and clarify the knowledge gap which will be reviewed in the Literature review section. It should avoid stating a detailed literature or a summary of the findings.
  8. Results should be expressed clearly and briefly.
  9. Discussion section should express the importance of the finding and should avoid repeating them.
  10. Conclusion section should focus on outcome of the research work.
  11. Appendices should be specified as A, B, etc. Formulae and equations in appendices should be numbered as follows: Eq. (A.1), Eq. (A.2), etc.; in a following appendix, Eq. (B.1) and so on. Correspondingly, for tables and figures: Table A.1; Fig. A.1, etc.
  12. The author(s) are responsible to name individuals or organizations providing them with financial supports in the acknowledgements section.

References

  1. References should include the manuscript titles.
  2. References should be cited successively in order of appearing in the text.
  3. All references cited in the text are contained in the references list.
  1. It is also suggested that the authors should refer to recent research which have carried out in the last 10 years.
  1. The style of the references should be in accordance with the journal style.
  2. Authors should use et al., for citations with more than three authors.
  3. The number of references adopted from each journal should not go beyond 5. It is suggested that the number of references should be more than 30 for original papers and more than 100 for review papers, for short communication 20 references are compulsory.

Tables and Figures

  1. All Tables and Figures should be numbered successively according to the order of appearance in the text.
  2. All Tables and Figures should be prepared based on the journal format.
  3. Authors must refer to all tables and figures in the text.
  4. Figure Legends should be written within the manuscript and not on the Figures.
  5. All symbols and abbreviations should be defined in the Legends.
  6. It is recommended that all Figures presented in an excel file.
  7. All Figures that are graphs and maps (not photos) are supplied as                                                                                         
         EPS - encapsulated postscript (or PDF): Vector drawings, embed all used fonts.             
         TIFF (or JPEG): Color or grayscale photographs (halftones), Bitmapped (pure black & white pixels) line drawings and Combinations bitmapped line/half-tone keep to a minimum of 700-1000 dpi.
  8. All maps should be provided with scales and north-south direction.

 

AFTER ACCEPTANCE

Use of the Digital Object Identifier

The Digital Object Identifier (DOI) is employed to cite the electronic documents. The DOI contains of a unique alpha-numeric character string which is allocated to a document by the publisher based on the initial electronic publication. The dedicated DOI never vary. The assigned DOI never changes, i.e., it is ensured that the DOIs never change when the authors use a DOI to refer to an electronic document.

 

Online Proof Correction

Medbiotech Journal will send an e-mail to Corresponding authors regarding online proofing system, which enable them to make correction online. The environment of Online Proof Correction is similar to MS Word: as well as revising the manuscript, authors can put comments on figures/tables and answer questions from the Copy Editor. This proof is used to check the typesetting, editing, integrity and accuracy of the text, tables and figures. Making considerable changes to the accepted manuscript will be only possible with the editor-in-chief's permission. It is essential to guarantee that all corrections will be sent back to us in one e-mail. Authors must check cautiously before sending the changes, since addition of further corrections cannot be guaranteed. Proofreading is the sole responsibility of the corresponding author.

 

 Offprints

The offprints can be downloaded from the Medbiotech Journal website as soon as the final corrected manuscripts are published.